|
1
|
Koh Y: Update in acute respiratory
distress syndrome. J Intensive Care. 2:22014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Del Sorbo L and Slutsky AS: Acute
respiratory distress syndrome and multiple organ failure. Curr Opin
Crit Care. 17:1–6. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guérin C, Reignier J, Richard JC, Beuret
P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et
al PROSEVA Study Group, : Prone positioning in severe acute
respiratory distress syndrome. N Engl J Med. 368:2159–2168. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mondrinos MJ, Kennedy PA, Lyons M,
Deutschman CS and Kilpatrick LE: Protein kinase C and acute
respiratory distress syndrome. Shock. 39:467–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carnesecchi S, Pache JC and
Barazzone-Argiroffo C: NOX enzymes: Potential target for the
treatment of acute lung injury. Cell Mol Life Sci. 69:2373–2385.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carnesecchi S, Dunand-Sauthier I, Zanetti
F, Singovski G, Deffert C, Donati Y, Cagarelli T, Pache JC, Krause
KH, Reith W and Barazzone-Argiroffo C: NOX1 is responsible for cell
death through STAT3 activation in hyperoxia and is associated with
the pathogenesis of acute respiratory distress syndrome. Int J Clin
Exp Pathol. 7:537-551.eCollection 20142014.
|
|
7
|
Meduri G, Bell W, Sinclair S and Annane D:
Pathophysiology of acute respiratory distress syndrome.
Glucocorticoid receptor-mediated regulation of inflammation and
response to prolonged glucocorticoid treatment. Presse Med.
40:e543-e5602011.
|
|
8
|
Vandevyver S, Dejager L, Tuckermann J and
Libert C: New insights into the anti-inflammatory mechanisms of
glucocorticoids: An emerging role for
glucocorticoid-receptor-mediated transactivation. Endocrinology.
154:993–1007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nixon M, Andrew R and Chapman KE: It takes
two to tango: Dimerisation of glucocorticoid receptor and its
anti-inflammatory functions. Steroids. 78:59–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Headley AS, Tolley E and Meduri GU:
Infections and the inflammatory response in acute respiratory
distress syndrome. Chest. 111:1306–1321. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meduri GU, Headley S, Kohler G, Stentz F,
Tolley E, Umberger R and Leeper K: Persistent elevation of
inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1
beta and IL-6 levels are consistent and efficient predictors of
outcome over time. Chest. 107:1062–1073. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lamontagne F, Briel M, Guyatt GH, Cook DJ,
Bhatnagar N and Meade M: Corticosteroid therapy for acute lung
injury, acute respiratory distress syndrome and severe pneumonia: A
meta-analysis of randomized controlled trials. J Crit Care.
25:420–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rocco PR, Souza AB, Faffe DS, Pássaro CP,
Santos FB, Negri EM, Lima JG, Contador RS, Capelozzi VL and Zin WA:
Effect of corticosteroid on lung parenchyma remodeling at an early
phase of acute lung injury. Am J Respir Crit Care Med. 168:677–684.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Confalonieri M, Annane D, Antonaglia C,
Santagiuliana M, Borriello EM and Meduri GU: Is prolonged low-dose
glucocorticoid treatment beneficial in community-acquired
pneumonia? Curr Infect Dis Rep. 15:158–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matthay MA, Song Y, Bai C and Jones KD:
The acute respiratory distress syndrome in 2013. Translational
Respiratory Medicine. 1:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thompson BT: Corticosteroids for ARDS.
Minerva Anestesiol. 76:441–447. 2010.PubMed/NCBI
|
|
17
|
Wajanaponsan N, Reade MC and Milbrandt EB:
Steroids in late ARDS? Crit Care. 11:3102007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hwangbo B, Lee HS, Lee JM, Kim MS, Kim HY,
Choi YJ and Zo JI: Low dose steroid therapy at an early phase of
acute respiratory distress syndrome after thoracic surgery. Chest
Journal. 126:719S-a-719S2004. View Article : Google Scholar
|
|
19
|
Fremont RD and Rice T: Low-dose steroids
in ARDS. Chest. 132:10952007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peter JV, John P, Graham PL, Moran JL,
George IA and Bersten A: Corticosteroids in the prevention and
treatment of acute respiratory distress syndrome (ARDS) in adults:
Meta-analysis. BMJ. 336:1006–1009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Higgins J and Altman DG: Assessing risk of
bias in included studies. Cochrane handbook for systematic reviews
of interventions. Wiley-Blackwell; Chichester: pp. 187–241. 2008,
View Article : Google Scholar
|
|
22
|
Weigelt JA, Norcross JF, Borman KR and
Snyder WH III: Early steroid therapy for respiratory failure. Arch
Surg. 120:536–540. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bernard GR, Luce JM, Sprung CL, Rinaldo
JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA,
et al: High-dose corticosteroids in patients with the adult
respiratory distress syndrome. N Engl J Med. 317:1565–1570. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marik P, Kraus P, Sribante J, Havlik I,
Lipman J and Johnson DW: Hydrocortisone and tumor necrosis factor
in severe community-acquired pneumonia. A randomized controlled
study. Chest. 104:389–392. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Confalonieri M, Urbino R, Potena A,
Piattella M, Parigi P, Puccio G, Porta R Della, Giorgio C, Blasi F,
Umberger R and Meduri GU: Hydrocortisone infusion for severe
community-acquired pneumonia: A preliminary randomized study. Am J
Respir Crit Care Med. 171:242–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Annane D, Sébille V and Bellissant E;
Ger-Inf-05 Study Group, : Effect of low doses of corticosteroids in
septic shock patients with or without early acute respiratory
distress syndrome. Crit Care Med. 34:22–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steinberg KP, Hudson LD, Goodman RB, Hough
CL, Lanken PN, Hyzy R, Thompson BT and Ancukiewicz M: National
Heart, Lung, and Blood Institute Acute Respiratory Distress
Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of
corticosteroids for persistent acute respiratory distress syndrome.
N Engl J Med. 354:1671–1684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meduri GU, Golden E, Freire AX, Taylor E,
Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone
infusion in early severe ARDS: results of a randomized controlled
trial. Chest. 131:954–963. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mikami K, Suzuki M, Kitagawa H, Kawakami
M, Hirota N, Yamaguchi H, Narumoto O, Kichikawa Y, Kawai M, Tashimo
H, Arai H, Horiuchi T and Sakamoto Y: Efficacy of corticosteroids
in the treatment of community-acquired pneumonia requiring
hospitalization. Lung. 185:249–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wan MH, Li J, Gong HL, Xue P, Zhu L, Chen
GY, Xia Q and Wen-Fu T: Clinical observation on the effect of
dexamethasone and Chinese herbal decoction for purgation in severe
acute pancreatitis patients. Chin J Integr Med. 17:141–145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ferguson N, Adhikari N, Cook D, Hand L,
Henzler D, Zhou Q, Meade M and Lamontagne F: Corticosteroid use in
ARDS patients enrolled in the oscillation for ARDS treated early
(oscillate) trial. Am J Respir Crit Care Med. 183:A11692011.
|
|
32
|
Azevedo AF, Miranda-Filho DB,
Henriques-Filho GT, Leite A and Ximenes RA: Randomized controlled
trial of pulse methyl prednisolonex placebo in treatment of
pulmonary involvement associated with severe leptospirosis.
[ISRCTN74625030]. BMC Infect Dis. 11:1862011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seam N, Meduri GU, Wang H, Nylen ES, Sun
J, Schultz MJ, Tropea M and Suffredini AF: Effects of
methylprednisolone infusion on markers of inflammation, coagulation
and angiogenesis in early acute respiratory distress syndrome. Crit
Care Med. 40:495–501. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu L, Li J, Huang YZ, Liu SQ, Yang CS,
Guo FM, Qiu HB and Yang Y: The effect of stress dose glucocorticoid
on patients with acute respiratory distress syndrome combined with
critical illness-related corticosteroid insufficiency. Zhonghua Nei
Ke Za Zhi. 51:599–603. 2012.(In Chinese). PubMed/NCBI
|
|
35
|
Thompson BT: Glucocorticoids and acute
lung injury. Crit Care Med. 31 Suppl 4:S253–S257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meduri GU, Golden E, Freire AX, Taylor E,
Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone
infusion in early severe ARDS: Results of a randomized controlled
trial. Chest. 131:954–963. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suter PM: Lung inflammation in ARDS -
friend or foe? N Engl J Med. 354:1739–1742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Annane D: Glucocorticoids for ARDS: Just
do it! Chest. 131:945–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
